Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 1
Journal homepage
387
Views
54
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Estrogens on the Interferon-γ Producing Cell Population of Mouse Splenocytes

Mako NAKAYALaboratory of Food Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University
,
Hirofumi TACHIBANALaboratory of Food Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University
&
Koji YAMADALaboratory of Food Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University
Pages 47-53 | Received 16 May 2005, Accepted 08 Sep 2005, Published online: 22 May 2014

  • 1) Kanda, N., and Watanabe, S., 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J. Invest. Dermatol., 120, 420–427 (2003).
  • 2) Ruh, M. F., Bi, Y., D’Alonzo, R., and Bellone, C. J., Effect of estrogens on IL-1β promoter activity. J. Steroid Biochem. Mol. Biol., 66, 203–210 (1998).
  • 3) Zhang, X., Wang, L., Zhang, H., Guo, D., Qiao, Z., and Qiao, J., Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages. Methods Find Exp. Clin. Pharmacol., 4, 169–173 (2001).
  • 4) Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M., and Clark, E. A., 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood, 104, 1404–1410 (2004).
  • 5) Nakaya, M., Yamasaki, M., Tachibana, H., and Yamada, K., IgM production of lymphocytes from C57BL/6N mice was stimulated by estrogen treated splenic adherent cells. Immunol. Lett., 98, 225–231 (2005).
  • 6) Chu, S., Nishi, Y., Yanase, T., Nawata, H., and Fuller, P. J., Transrepression of estrogen receptor beta signaling by nuclear factor-kappaB in ovarian granulosa cells. Mol. Endocrinol., 8, 1919–1928 (2004).
  • 7) Hennessy, B. A., Harvey, B. J., and Healy, V., 17Beta-estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol. Cell. Endocrinol., 229, 39–47 (2005).
  • 8) Kuiper, G. G., Enmark, E., Penlto-Huikko, M., Nilsson, S., and Gustafsson, J. A., Cloning of a novel receptor expressed in rat prostate and ovary. Natl. Acad. Sci. U.S.A., 93, 5925–5930 (1996).
  • 9) Green, S., Walter, P., Greene, G., Krust, A., Goffin, C., and Jensen, E., Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem., 24, 77–83 (1986).
  • 10) Erlandsson, M. C., Jonsson, C. A., Islander, U., Ohlsson, C., and Carlsten, H., Oestrogen receptor specificity in estradiol-mediated effects on B lymphopoiesis and immunogloblin production in male mice. Immunology, 108, 346–351 (2003).
  • 11) Curran, E. M., Berghaus, L. J., Vernetti, N. J., Saporita, A. J., Lubahn, D. B., and Estes, D. M., Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respond to estrogen via a non-estrogen receptor-alpha-mediated pathway. Cell Immunol., 214, 12–20 (2001).
  • 12) You, H. J., Choi, C. Y., Jeon, Y. J., Chung, Y. C., Kang, S. K., Hahm, K. S., and Jeong, H. G., Suppression of inducible nitric oxide synthase and tumor necrosis factor-alpha expression by 4-nonylphenol in macrophages. Biochem. Biophys. Res. Commun., 294, 753–759 (2003).
  • 13) Chen, Z., Yuhanna, I. S., Galcheva-Garegova, Z., Karas, R. H., Mendelson, M. E., and Shaul, P. W., Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest., 103, 401–406 (1999).
  • 14) Nakaya, M., Yamasaki, M., Miyazaki, Y., Tachibana, H., and Yamada, K., Estrogenic compounds suppressed interferon-gamma production in mouse splenocytes through cell–cell interaction. In Vitro Cell. Dev. Biol. Anim., 39, 383–387 (2003).
  • 15) Mendes, R., Bromelow, K. V., Westby, M., Galea-Lauri, J., Smith, I. E., O’Brien, M. E. R., and Souberbielle, B. E., Flow cytometric visualization of cytokine production by CD3−CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood. Cytometry, 39, 72–78 (2000).
  • 16) Bbendelac, A., Rivera, M. N., Park, S. H., and Roak, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Ann. Rev. Immunol., 15, 535–562 (1997).
  • 17) Roger, A., and Eastell, R., Effect of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J. Bone Miner. Res., 13, 1577–1586 (1998).
  • 18) Deshpande, R., Khalili, H., Pergolizzi, G. R., Michael, D. S., and Chang, Y. M., Estradiol down-regulates LPS-induced cytokine production and NFκB activation in murine macrophages. Am. J. Reprod. Immunol., 38, 46–54 (1997).
  • 19) Fox, S. H., BonD, L. B., and Parslow, G. T., Estrogen regulates the IFN-γ promoter. J. Immunol., 146, 4362–4367 (1991).
  • 20) Nancy, J., O’Neil-Andersen, and Lawrence, A. D., Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A. Clin. Diagn. Lab. Immunol., 9, 243–250 (2002).
  • 21) Caraher, M. E., Parenteau, M., Gruber, H., and Scott, W. F., Flow cytometric analysis of intracellular IFN-γ, IL-4 and IL-10 in CD3+4+ T-cells from rat spleen. J. Immunol. Methods, 244, 29–40 (2000).
  • 22) Varma, T. K., Lin, C. Y., Toliver-Kinsky, T. E., and Sherwood, E. R., Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors. Clin. Diagn. Lab. Immunol., 3, 530–543 (2002).
  • 23) Godfrey, I. D., Hammond, J. L. K., Poulton, D. L., Smyth, J. M., and Baxter, G. A., NKT cells: facts, functions and fallacies. Immunology Today, 21, 573–583 (2000).
  • 24) Kisielow, P., Development and selection of T cells: how many subsets? How many rules? Arch. Immunol. Ther. Exp. (Warsz), 51, 407–414 (2003).
  • 25) Tomita, M., Irwin, I. K., Xie, Z., and Santoro, J. T., Tea pigments inhibit the production of type 1 (TH1) and type 2 (TH2) helper T cell cytokines in CD4+ T cells. Phytother. Res., 16, 36–42 (2003).
  • 26) Utsuyama, M., Kanno, J., Inoue, T., and Hirokawa, K., Age/sex dependent and non-monotonous dose-response effect of diethylstilbestrol on the immune functions in mice. Toxicol. Lett., 135, 145–153 (2002).
  • 27) Albrecht, A. E., Hartmann, B. W., Scholten, C., Huber, J. C., Kalinowska, W., and Zielinski, C. C., Effect of estrogen replacement therapy on natural killer cell activity in postmenopausal women. Maturitas, 3, 217–222 (1996).
  • 28) Takao, T., Kumagai, C., Hisakawa, N., Matsumoto, R., and Hashimoto, K., Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J. Endocrinol., 184, 191–197 (2005).
  • 29) Garidou, L., Laffont, S., Douin-Echinard, V., Coureau, C., Krust, A., Chambon, P., and Guery, J. C., Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol., 173, 2435–2442 (2004).
  • 30) Staples, J. E., Gasiewicz, T. A., Fiore, N. C., Lubahn, D. B., Korach, K. S., and Silverstrone, A. E., Estrogen receptor alpha is necessary in thymic dependent and estradiol-induced thymic alterations. J. Immunol., 163, 4168–4174 (1999).
  • 31) Erlandsson, M. C., Ohlsson, C., Gustafsson, J. A., and Carlsten, H., Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effect on thymus. Immunology, 103, 17–25 (2001).
  • 32) Sakazaki, H., Ueno, H., and Kakamuro, K., Estrogen receptor α in mouse splenic lymphocytes: possible involvement in immunity. Toxicol. Lett., 133, 221–229 (2002).
  • 33) Harris, H. A., Katzenellenbogen, J. A., and Katzenellenbogen, B. S., Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology, 143, 4172–4177 (2002).
  • 34) Meyers, M. J., Sun, J., Carlson, K. E., Marriner, G. A., Katzenellenbogen, B. S., and Katzenellenbogen, J. A., Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem., 44, 4230–4251 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.